Facebook Pixel Code
x
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Multinational Biotechnology Companies and their Lobby Group Essay Example

Show related essays

Multinational Biotechnology Companies and their Lobby Group

This is a preview of the 12-page document
Read full text

Multinational Biotechnology Companies and their Lobby Group. Eurofins are the world leaders in food and feed testing. They undertake nutritional testing, analyses for traces of residues and pesticides, allergen testing and determining the origin and authenticity. However, there is strong consumer resistance and the acceptability of such food is low. Eurofins contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring, and consultancy services to a wide range of industrial companies, environmental consultants, contractors, retailers, and government authorities. They are the global market leaders in dioxin testing. The data supplied by them can be relied upon which is why they have been appointed by the Danish government as National Reference Laboratory for testing soil and water.

The robust quality of the food, pharma, and environmental testing markets is evident from the growth in revenues by 33 percent in 2008 (Media center, 2008). Despite a strong position Eurofins faces certain challenges due to macro drivers like regulations, the global supply chain, and consumer awareness.
Eurofins is planning to close two European facilities and one US site as they want to consolidate and assign assets (GenomeWeb, 2007). It has recently acquired three genomics companies with facilities in Germany and the US and Japan. This has taken place to the competitive market scenario as there is overcapacity in the market and investments are not justified.
Until the mid-1990s, Europe’s biotech industry was closely modeled on the strategies and institutional support structures as in the United States. Any commercialization of biotech research took place directly between academics and the pharmaceutical company. Some firms go in for royalty-bearing licensing like Mycogen to Ciba while others have non-loyalty bearing licensing like AgrEvo and then some even enter into royalties and fees like Monsanto (Renkoski, 1997).
The German biotech industry has suddenly taken off whereas the UK biotech industry has become stagnant. According to Casper and Kettler (2001), there is no one right way to organize commercial biotechnology. Multinational Biotechnology Companies and their Lobby Group.

This is a preview of the 12-page document
Open full text

Reference

Ahson, K 1997, What is actually happening in agro-food biotechnology?, Nutrition & Food Science, no. 1, pp. 26–31

Bose, S & Oh, KB 2005, Measuring strategic value-drivers for managing intellectual capital, The Learning Organization, vol. 11, no. 4/5, pp. 347-356

Casper, S & Matraves, C 2003, Institutional frameworks and innovation in the German and UK pharmaceutical industry, Research Policy, vol. 32, pp. 1865–1879

Casper, S & Kettler, H 2001, National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The Germany and UK Biotechnological Sectors, Industry and Innovation, vol. 8.

Demirbas, D 2003, The EU Regulation on GMOs, Multinational Biotechnology Companies and their lobby group, Eubios Journal of Asian and International Bioethics, vol. 13, pp. 11-15. retrieved online 22 April 2009, from

http://eubios.info/EJ131/ej131h.htm

D’Souza, C & Quazi, A 2005, The dynamics of exploring future market potential of genetically modified foods, Nutrition & Food Science, vol. 35, no. 2, pp. 95-108

Eurofins, 2009, About Eurofins, retrieved online 22 April 2009, from http://www.eurofins.com/en.aspx

EurActiv, 2005, Biotech industry wants better implementation of EU regulations, retrieved online 22 April 2009, from http://www.euractiv.com/en/health/biotech-industry-wants-better-implementation-eu-regulations/article-144738

Finegold, D & Moser, A 2006, Ethical decision-making in bioscience firms, retrieved online 22 April 2009, from http://www.nature.com/nbt/journal/v24/n3/full/nbt0306-285.html

GenomeWeb, 2007, Eurofins to Close Three Facilities as Operon, MWG, and Medigenomix Subsidiaries Form Genomics Joint Venture, retrieved online 22 April 2009, from

http://www.genomeweb.com/eurofins-close-three-facilities-operon-mwg-and-medigenomix-subsidiaries-form-gen

Gurau, C 2004, Positioning strategies in the value-added chain of the biopharmaceutical sector: the case of UK SMEs, Journal of Consumer Marketing, vol. 21, no. 7, pp. 476-485

Knight, JG Mather, DW & Holdsworth, DK 2005, Genetically modified crops and country image of food exporting countries British Food Journal, vol. 107, no. 9, pp. 653-662

Mangematin, V Lemarié, S Boissin, J Catherine, D Corolleur, F Coronini, R & Trommetter, M 2003, Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France, Research Policy, vol. 32, pp. 621–638

Media Centre, 2008, Eurofins continues to experience robust growth; sales increase 33% in Q3 2008, retrieved online 22 April 2009, from http://www.eurofins.com/en/media-centre/press-releases/2008-11-13.aspx

Nilsson, A 2001, Biotechnology Firms in Sweden, Small Business Economics, vol. 17, pp. 93–103

O’Donnell, P 2007, European Biotech Industry Goes on GMO Offensive, retrieved online 22 April 2009, from http://www.soyatech.com/news_story.php?id=5877

Renkoski, MA 1997, Marketing Strategies of Biotechnology Firms: Implications for U.S. Agriculture, Journal of Agricultural and Applied Economics, vol. 29, no. 1, pp. 123–128

Swann, P & Pervezer, M 1996, A comparison of the dynamics of industrial clustering in computing and biotechnology, Research Policy, vol. 25, pp. 1139-I 157

Tucker, G 1996, Biotechnology and enzymes in the food industry, British Food Journal, vol. 98, no. 4/5, pp. 14–19

Close ✕
Tracy Smith Editor&Proofreader
Expert in: Technology, Military, Information Technology
Hire an Editor
Matt Hamilton Writer
Expert in: Technology, Engineering and Construction, Agriculture
Hire a Writer
preview essay on Multinational Biotechnology Companies and their Lobby Group
  • Pages: 12 (3000 words)
  • Document Type: Essay
  • Subject: Technology
  • Level: Undergraduate
WE CAN HELP TO FIND AN ESSAYDidn't find an essay?

Please type your essay title, choose your document type, enter your email and we send you essay samples